Genix Pharmaceuticals Corp
XTSX:GENX
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| CA |
|
Genix Pharmaceuticals Corp
XTSX:GENX
|
1.2m CAD |
Loading...
|
|
| FR |
|
L'Oreal SA
PAR:OR
|
198.4B EUR |
Loading...
|
|
| UK |
|
Unilever PLC
LSE:ULVR
|
118.4B GBP |
Loading...
|
|
| IN |
|
Hindustan Unilever Ltd
NSE:HINDUNILVR
|
5.4T INR |
Loading...
|
|
| UK |
|
HALEON PLC
LSE:HLN
|
36.7B GBP |
Loading...
|
|
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
38.9B USD |
Loading...
|
|
| DE |
|
Beiersdorf AG
XETRA:BEI
|
23.5B EUR |
Loading...
|
|
| JP |
|
Kao Corp
TSE:4452
|
3.1T JPY |
Loading...
|
|
| IN |
|
Godrej Consumer Products Ltd
NSE:GODREJCP
|
1.2T INR |
Loading...
|
|
| IN |
|
Dabur India Ltd
NSE:DABUR
|
909B INR |
Loading...
|
|
| CA |
|
Relevium Technologies Inc
XTSX:RLV
|
12.2B CAD |
Loading...
|
Market Distribution
| Min | -10 058.3% |
| 30th Percentile | 20.4% |
| Median | 33.6% |
| 70th Percentile | 50.5% |
| Max | 717.4% |
Other Profitability Ratios
Genix Pharmaceuticals Corp
Glance View
Genix Pharmaceuticals Corp. engages in the the research, development, manufacture, licensing and sales of novel and innovative healthcare products, particularly proprietary over the counter nutraceuticals and generic pharmaceuticals. The company is headquartered in Vancouver, British Columbia. The firm focused on developing and licensing novels and products for sales through retail outlets and well as direct to consumers and e-commerce platforms. The firm holds licensing agreement for a range of products, including 30 Ophthalmic drugs, Sucanon, Renochlor, Flu-X, and Levothyroxine sodium (generic Synthroid). Flu-X anti-viral spray is an herbal, oral, anti-viral, anti-flu and anti-cold virus spray. Renochlor is an aid in the restoration of kidney health and kidney function. Sucanon is a natural substitute for prescription pharmaceuticals for non-insulin dependent diabetes patients.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Genix Pharmaceuticals Corp is -1 000%, which is below its 3-year median of -64.7%.
Over the last 3 years, Genix Pharmaceuticals Corp’s Gross Margin has decreased from 50% to -1 000%. During this period, it reached a low of -1 000% on Aug 31, 2025 and a high of 68.4% on Apr 30, 2024.
